These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas. Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158 [TBL] [Abstract][Full Text] [Related]
3. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer. Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma. Kim A; Kwon T; You D; Jeong IG; Go H; Cho YM; Hong JH; Ahn H; Kim CS J Korean Med Sci; 2015 Apr; 30(4):385-9. PubMed ID: 25829805 [TBL] [Abstract][Full Text] [Related]
5. Histological variants of prostatic carcinoma and their significance. Humphrey PA Histopathology; 2012 Jan; 60(1):59-74. PubMed ID: 22212078 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical verification of ductal differentiation in prostate cancer. Tarján M; Lenngren A; Hellberg D; Tot T APMIS; 2012 Jun; 120(6):510-8. PubMed ID: 22583364 [TBL] [Abstract][Full Text] [Related]
7. Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations. Fine SW Adv Anat Pathol; 2012 Jul; 19(4):204-16. PubMed ID: 22692283 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic Mixed Acinar-neuroendocrine-ductal Carcinoma: A Case Report and Literature Review. Sakaguchi R; Yamada R; Nose K; Tanaka T; Murashima Y; Tsuboi J; Nakagawa H Intern Med; 2023 Nov; 62(22):3347-3353. PubMed ID: 37032087 [TBL] [Abstract][Full Text] [Related]
9. [A prostatic duct carcinoma difficult to distinguish from transitional cell carcinoma: a case report]. Ushida H; Koizumi S; Okada Y Hinyokika Kiyo; 2004 Aug; 50(8):535-8. PubMed ID: 15471072 [TBL] [Abstract][Full Text] [Related]
10. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists. Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087 [No Abstract] [Full Text] [Related]
11. Ductal Spread Versus High-Grade Prostatic Intraepithelial Neoplasia: A Diagnostic Pitfall. Acosta AM; Sharif A; Groth JV; Kajdacsy-Balla A Int J Surg Pathol; 2016 Dec; 24(8):718-719. PubMed ID: 27605089 [TBL] [Abstract][Full Text] [Related]
12. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type. Au S; Villamil CF; Alaghehbandan R; Wang G Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651 [TBL] [Abstract][Full Text] [Related]
13. My approach to intraductal lesions of the prostate gland. Pickup M; Van der Kwast TH J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185 [TBL] [Abstract][Full Text] [Related]
14. Rare histological patterns of prostatic ductal adenocarcinoma. Lee TK; Miller JS; Epstein JI Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402 [TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine-type prostatic adenocarcinoma with microsatellite instability in a patient with lynch syndrome. Wagner DG; Gatalica Z; Lynch HT; Kohl S; Johansson SL; Lele SM Int J Surg Pathol; 2010 Dec; 18(6):550-3. PubMed ID: 20798067 [TBL] [Abstract][Full Text] [Related]
16. Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin. Lindh C; Samaratunga H; Delahunt B; Bergström R; Chellappa V; Yaxley J; Lindberg J; Egevad L Prostate; 2022 Apr; 82(5):576-583. PubMed ID: 35049068 [TBL] [Abstract][Full Text] [Related]
17. [Papillary adenocarcinoma of the prostate: report of 4 cases]. Miki J; Ikemoto I; Shimomura T; Kiyota H; Oisi Y; Kondo I; Madarame J; Endo K; Takahashi H Hinyokika Kiyo; 2003 Jan; 49(1):21-4. PubMed ID: 12629776 [TBL] [Abstract][Full Text] [Related]
18. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F; Epstein JI Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142 [TBL] [Abstract][Full Text] [Related]
19. Contemporary Comparison of Clinicopathologic Characteristics and Survival Outcomes of Prostate Ductal Carcinoma and Acinar Adenocarcinoma: A Population-Based Study. Knipper S; Preisser F; Mazzone E; Mistretta FA; Tian Z; Briganti A; Zorn KC; Saad F; Tilki D; Graefen M; Karakiewicz PI Clin Genitourin Cancer; 2019 Jun; 17(3):231-237.e2. PubMed ID: 31080021 [TBL] [Abstract][Full Text] [Related]
20. Adenocarcinomas of the prostatic duct in necropsy material. Stamatiou K; Alevizos A; Mariolis A; Fanou D; Alevizou A; Michalodimitrakis E; Sofras F Can J Urol; 2007 Apr; 14(2):3502-6. PubMed ID: 17466156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]